Welcome to the Life Sciences blog.

Here you will find articles and insights about life sciences and healthcare.

カテゴリーなし
January 29, 2021

Regulatory response to the COVID-19 pandemic: Careful planning to minimize disruptions
Case Studies
December 11, 2020

Understanding local CMC requirements in low-resource countries
カテゴリーなし
November 25, 2020

Delays in clinical trials present opportunities for pharma companies to evolve
カテゴリーなし
November 2, 2020

Biomarkers have several key roles in clinical trials and precision medicine
Kenan Patel
VP, Cortellis Product Platform
Clarivate
カテゴリーなし
October 6, 2020

Digital innovation in drug development: Perspectives from pharma, tech and regulatory experts
Francesco Dellisanti
Director of Digital Health
Clarivate
カテゴリーなし
September 1, 2020

Resilient supply chain requires geographic diversity
Mari Serebrov
Regulatory Editor, BioWorld
Clarivate
Case Studies
August 31, 2020

Identifying and evaluating new products to rise above the competition
カテゴリーなし
August 20, 2020

The future of continuous manufacturing in pharma
Case Studies
August 12, 2020

Securing the best price for an out-licensed asset
カテゴリーなし
August 10, 2020

Patient enrollment continues to be a limiting factor for trial durations
Teresa Fishburne
Head of Centre for Medicines Research
Clarivate
カテゴリーなし
August 6, 2020

Understanding disruptions to the antibiotic supply resulting from COVID-19
Nicole Reynolds
Solutions Consultant
Clarivate
Case Studies
July 16, 2020

Conducting pathway analyses to accelerate discovery research
カテゴリーなし
July 13, 2020

Gaining insight with artificial intelligence
カテゴリーなし
July 13, 2020

Organ-specific toxicity and personalized approaches
カテゴリーなし
July 13, 2020

Identifying risks in drug discovery